LAURA ANDERSON: Open Payments
NPI 1629726369 · MISSION, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,762 in 30 payments from 16 companies in 2025. Trend: 2023 $835 · 2024 $761 · 2025 $1,762
Food & beverage: $1,762
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 4 | $311 |
| Biosense Webster, Inc. | 2 | $292 |
| Novartis Pharmaceuticals Corporation | 8 | $178 |
| Amgen Inc. | 1 | $137 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $124 |
| Exeltis, USA Inc. | 1 | $124 |
| GlaxoSmithKline, LLC. | 1 | $122 |
| Averitas Pharma Inc. | 1 | $113 |
| E.R. Squibb & Sons, L.L.C. | 1 | $109 |
| Edwards Lifesciences Corporation | 1 | $108 |
Products named: CARTO 3, LEQVIO, WATCHMAN FLX, FARAPULSE, LifeVest, AREXVY, QUTENZA, CAMZYOS.
Industry payments across KS — which companies pay providers there.
